1. Home
  2. PCVX vs WCC Comparison

PCVX vs WCC Comparison

Compare PCVX & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • WCC
  • Stock Information
  • Founded
  • PCVX 2013
  • WCC 1922
  • Country
  • PCVX United States
  • WCC United States
  • Employees
  • PCVX N/A
  • WCC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • WCC Telecommunications Equipment
  • Sector
  • PCVX Health Care
  • WCC Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • WCC Nasdaq
  • Market Cap
  • PCVX 4.4B
  • WCC 8.1B
  • IPO Year
  • PCVX 2020
  • WCC 1999
  • Fundamental
  • Price
  • PCVX $35.28
  • WCC $198.26
  • Analyst Decision
  • PCVX Strong Buy
  • WCC Buy
  • Analyst Count
  • PCVX 10
  • WCC 8
  • Target Price
  • PCVX $136.50
  • WCC $212.63
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • WCC 606.9K
  • Earning Date
  • PCVX 08-05-2025
  • WCC 07-31-2025
  • Dividend Yield
  • PCVX N/A
  • WCC 0.91%
  • EPS Growth
  • PCVX N/A
  • WCC 10.34
  • EPS
  • PCVX N/A
  • WCC 13.26
  • Revenue
  • PCVX N/A
  • WCC $21,812,500,000.00
  • Revenue This Year
  • PCVX N/A
  • WCC $4.26
  • Revenue Next Year
  • PCVX N/A
  • WCC $4.26
  • P/E Ratio
  • PCVX N/A
  • WCC $14.96
  • Revenue Growth
  • PCVX N/A
  • WCC N/A
  • 52 Week Low
  • PCVX $27.66
  • WCC $125.21
  • 52 Week High
  • PCVX $121.06
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 54.47
  • WCC 66.69
  • Support Level
  • PCVX $31.79
  • WCC $197.00
  • Resistance Level
  • PCVX $36.89
  • WCC $203.83
  • Average True Range (ATR)
  • PCVX 1.55
  • WCC 4.74
  • MACD
  • PCVX 0.37
  • WCC 0.57
  • Stochastic Oscillator
  • PCVX 68.43
  • WCC 74.72

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

Share on Social Networks: